In March 2025, the company announced new plans for any immediate-to-shopper offering of its Wegovy weight loss drug. The company proven a whole new pharmacy, known as NovoCare, which might cost buyers $499 every month for access to the drug, fewer than 50 % the cost of the drug as a result of other pharmaceutical distribution networks.[53]inflammat